CEO of Sanara Ventures Chairman, Life Science Advisory Board at The Israel Export Institute
Mr. Assaf Barnea, CEO of Sanara Ventures is a seasoned entrepreneur and venture professional with significant multidisciplinary experience in building innovation platforms and commercialization processes in healthcare and Cleantech. Sanara Ventures is a healthcare investment platform, jointly held by Teva Pharmaceuticals and Philips Healthcare.
Assaf is also a business consultant at the World bank/IFC venture capital team, supporting the IFC’s investments in technologies that are relevant for developing countries. Formerly, Assaf was the CEO of Kinrot Ventures, the leading seed investor in water technologies worldwide.
Kinrot is privately held by Hutchison water that acquired Kinrot Ventures in 2012. Previously, Assaf was managing the Business Development activity at Mekorot, Israel’s national water company, where he oversaw the establishment of WaTech – the Entrepreneurship & Parmball at Israel’s top division and was a member of the Israeli national basketball team. In April 2013, Mr. Barnea was awarded with the Innovation Hero Award by the global Cleantech groupKEEP READING
Director, Division of Medicine, Maccabi HealthCare Services Born in Israel 1961. Married to Shifra (pediatric oncologist) and father to twin boys and a daughter. Received his MD degree
from Sackler School of Medicine, Tel Aviv University in 1986. Completed his residency in Internal Medicine in 1997.
In 2001 Prof. Ash received MS degree in Medical Informatics from the Harvard-MIT Division of Health, Sciences and Technology, Boston, USA. Prof. Ash has also a Master degree in political sciences from the University of Haifa.
Prof. Ash has been a military physician for 25 years. He retired in the rank of Brigadier General on 2011, after completing intensive 4 years as the Surgeon General of the IDF.
During this position Prof. Ash was in charge of deploying a field hospital to Haiti (Jan. 2010) and Japan (Apr. 2011) during the natural disasters that came upon these countries.
Between Jan 2012 and July 2013 Prof. Ash served in the Ministry of Health as a senior Deputy Director General for Health Informatics. In this position he was responsible for Health Information Technology and Information Management in the Israeli health system. On August 2013 Prof. Ash joined Maccabi Healthcare Services (MHS), the second largest HMO in Israel, as the chief Director of "Sharon" district.
A year later he was promoted to be the Director of the Health Division of MHS Also serving as Deputy CEO for Health Affairs, a position that he holds currently. Nachman Ash is a Professor at Ariel University, the school of Health Sciences, the department of health systems management.KEEP READING
Head of the Foreign Trade Administration, Ministry of Economy and Industry, Israel
A diplomat specializing in international trade, Ohad Cohen was appointed Head of the Ministry of Economy and Industry’s Foreign Trade Administration in May 2012. As Director of the Foreign Trade Administration, he leads an organization with a staff of over 250, an annual budget of 220 million NIS and 50 trade offices worldwide.
The Foreign Trade Administration at the Israeli Ministry of Economy and Industry directs Israel’s trade policy and promotes Israel’s high-tech and traditional industries worldwide by supporting and boosting Israeli exports, attracting foreign direct investment to Israel, facilitating strategic partnerships between Israeli and foreign governments and companies, fostering robust relations between Israeli and foreign industries , and initiating and managing Israel’s trade agreements. He served in the IDF from 1989 to 1993, after which he earned a BA in Economics and a Masters of Business Administration at the University of Haifa.
After graduating university, he joined Israel’s Ministry of Economy and Industry where he worked in the Foreign Trade Administration in its Middle East Department. In 1998, he was appointed Commercial Attaché in Amman, Jordan, where he also led the Israeli delegation to the joint Israeli-Jordanian Qualified Industrial Zone (QIZ) Committee.
From 2000 to 2004 he served as Commercial Attaché to Sweden, Finland and Norway. He then returned to Israel to Lead the Commercial Attaché Cadets Course, making him responsible for training the next generation of Israel’s diplomatic commercial specialists.
From 2007 to 2012 Mr. Cohen served as Commercial Attaché at the Israeli Embassy in Washington DC.
Mr. Cohen was born in Israel, is married to Monika and has three children.KEEP READING
Chairman of Sun Pharma
Chairman of Bio-Light life Sciences Ltd.
Chairman of Micromedic Technologies Ltd.
Mr Israel Makov is Chairman of SUN Pharmaceutical Industries Limited – the world’s 5th largest specialty generic pharma company, the Chairman of BioLight – an emerging global ophthalmic company focused on the discovery, development and commercialization of products for ophthalmic conditions and Chairman of Micromedic Technologies Ltd. – a cluster of companies engaged in cancer diagnostics.
Mr Makov is the former Chairman of Given Imaging – the developer and world’s leading provider of capsule endoscopy and Netafim – the pioneer and global leader in smart irrigation solutions.
Mr. Makov is the former President & CEO of Teva Pharmaceutical Industries Ltd. He led the company’s global expansion and under his leadership Teva became the undisputed global leader in the generic pharmaceutical industry and a global leader in the treatment of Multiple sclerosis.
Mr Makov is a member of the Board of Directors of the Israel National Nanotechnology Initiative, an initiative he also helped found. He is a member of the Executive Board & Management Committee of the Weizmann Institute of Science, on the Board of Governors of the Technion – Israel Institute of Technology and President of the Friends of Schneider Children’s Medical Center of Israel. Mr. Makov is also Chairman of the Friends of Gesher Theatre, one of Israel’s leading theaters, and is involved in many other charitable activities.KEEP READING
Michal Geva is the Founder and Managing Partner of Triventures, a venture capital fund focused on transformational health which includes medical device and data driven digital health technologies in Israel and the United States.
Michal Geva has over 20 years of experience in medtech startups both in Israel and the US in a variety of executive positions.
Ten years ago, Michal identified that it is not sufficient for a startup to have a strong, innovative core technology, but in order to realize success abroad, it is critical to have a deep understanding of commercial integration into the healthcare systems. With this principle in mind, she started Triventures and was the first woman to found and manage a venture capital fund in Israel.
Together with her Co Founder, Dr. Peter Fitzgerald, she has built a strong syndicate of strategic investor to the fund, which include top tier medtech, Healthcare organizations, and consumer electronic companies such as Medtronic, Johnson & Johnson, Boston Scientific, Abbott Laboratories, Philips, St. Jude Medical, Cardinal Health, Intermountain Healthcare, Samsung and Nikon.
Prior to Triventures, Michal held executive roles in a number of startups in Israel and Silicon Valley including ByPass (collaborated with J&J), AST (acquired by Boston Scientific) and GI View.
In 2017 Michal was duly recognized as one of the 50 most influential women in Israel by Globes, Israel’s leading financial journal. Michal is involved in all the fund’s major decisions and investments and has served as an active board member in the majority of the portfolio companies.
Angela W. Rabinovich is leading Life Science industry department at the Israeli Export and International Cooperation Institute. IEICI is a not-for-profit organization supported by the government of Israel and the private sector to advance the integration of Israeli companies into the global market.
On the daily base Angela is responsible for constant interaction with more than 500 Israeli exporters in the field of Medical Devices, Health Care IT and BioPharma: analyzing their needs, identifying target markets and business opportunities generating export oriented activities (form formal delegations to tailor made business visits).
Israeli National Pavilion at Medica (Germany), Hospitalar (Brazil) exhibitions, North American Hospital CEO Delegation and MEDinISRAEL are among recent successful projects under Angela’s leadership.
Her professional career started in 2004 at Orgenics Ltd. Under her first responsibility were products’ registration projects in Eastern Europe countries; later as Customer and Sales Manager for CIS countries. Since Orgenics has been owned by Inverness Medical Innovation, today Aler (based in US) Angela has been promoted for Business Development Manager for Asia Pacific region.
During that period she acquired wide experience in such fields like SelfCare, Point of Care and Rapid Diagnostics for Infectious Disease, Cardiovascular, Oncology, Women Health as well as in Clinical Laboratories diagnostic & research tools.
Principal Competitors: Wyeth Pharmaceuticals; Abbott Laboratories; Roche Group. Angela holds BA in International Relations and EMBA from the Hebrew University in Jerusalem. Angela is fluent in English, Hebrew, Russian and Ukrainian.KEEP READING
Elisheva is a senior marketer and an active member of the country leadership board responsible for all corporate brand communication, public and government affairs.
Prior to that she was responsible for the business of Philips Consumer Electronics alongside the Philips brand reponsibilities in the Israeli market.
Before joining Philips Elisheva held a few global sales and marketing positions at ZAG Industries later acquired by Stanley Tools, a fortune 500 company in the area of DIY cosumer goods.
She has a BA in Humanities from Hebrew University, Jerusalem.KEEP READING
Prof. Ran Balicer, MD, PhD, MPH serves as Founding Director of the Clalit Research Institute, the WHO Collaborating Center on Non-Communicable Diseases Research, Prevention and Control. In Parallel, he serves as Director of Innovation and Director of the Health Policy Planning Dpt. for Clalit – Israel’s largest healthcare organization.
In these roles, he is responsible for strategic planning of novel organization-wide interventions for improving healthcare quality, reducing disparities and increasing effectiveness.
These include the introduction of innovative data-driven tools into practice – predictive modeling, real-life effectiveness studies, decision support tools and proactive care models.
Prof Balicer serves as a Public Health Professor and MPH Track Director at Israel’s Ben-Gurion University, as Chair of the Israeli Society for Quality in Healthcare, and as an Advisor to the World Health Organization, in projects focusing on non-communicable diseases monitoring, prevention and control, Healthy Aging and Integrated Healthcare Systems.KEEP READING
Rafael Beyar, MD, DSc, MPH, and Professor of Medicine and Biomedical Engineering, is the director of Rambam Health Care Campus, since 2006, a leading academic referral hospital in Northern Israel. Beyar received his MD from Tel Aviv University (1977), a DSc from the Technion (1983), and his MPH from the Bloomberg School of Public Health (2008). He trained at Johns Hopkins Cardiology and has held a visiting Professor appointment there. Beyar served as Dean of the Technion’s Ruth & Bruce Rappaport Faculty of Medicine (1999–2005); under his leadership, Professors Avram Hershko and Aaron Ciechanover were awarded the Nobel Prize in Chemistry in 2004. An interventional cardiologist with research focusing on cardiovascular engineering, development of stents, and the first robotic coronary catheterization system, Beyar has authored numerous publications, several patents, 15 books, and is a recipient of several awards.
Beyar successfully led the hospital staff through the 2006 Second Lebanon War, during which the hospital was under fire. Following the war, Beyar led the hospital through a massive development plan with a vision that emphasizes the intertwining of superb medical care with education, research, and innovation. He led the administration in building a new campus with a 2,000-bed fortified underground emergency hospital, a modern children’s hospital, an advanced oncology center and an interdisciplinary heart hospital. The Health Discovery Tower, at the center of the campus, is a joint project with the University of Haifa and the Technion—integrating clinical, academic, and industry activities. Beyar also spearheaded the founding of Rambam MedTech, the hospital’s technology transfer company and has led the hospital towards an innovative, first of a kind, joint effort with Medtronic, IBM, and Pitango-Impact First, to establish the MindUp Incubator on Digital Health in early 2016 in Haifa.
Prof. Victor Novack MD, PhD is the founding director of Soroka-BGU Medical Research Institute and Head of the Research Authority at Soroka University Medical Center, the second largest hospital in Israel and a single provider of the tertiary care to a population of 1.2 mln. Prior to his current position, Prof. Novack served as a Medical Director at Harvard Clinical Research Institute, Boston USA. His epidemiology training allows for the bridging a gap between the clinical questions and statistical apparatus. He has designed and contributed to the design of more than 50 feasibility and pivotal trials for FDA approval. Prof. Novack is Professor of Medicine at Faculty of Health Sciences at Ben-Gurion University, attending in the Division of Medicine at Soroka University Medical Center and Senior Scientist at Beth Israel Deaconess Medical Center, Harvard Medical School. He is an Associate and Statistical Editor of the European Journal of Internal Medicine. He has more than 170 scientific publications in peer reviewed journals. His scientific interests lays at the application of the evolving statistical and epidemiological methodology to the clinically driven research questions.KEEP READING
CEO EarlySense Board Member, Life Science Directorate at IEI Mr. Halperin is a veteran high tech executive. He has served in several senior management positions including CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and VP of Business Development at Lenslet. He also worked as the R&D Manager at Eldat and was the Department Head of an R&D Unit in the IDF Intelligence Corps. Mr. Halperin earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from the MIT Sloan Fellows Executive MBA Program. He is the author of over 20 US Patents and lectures at the University of Jerusalem School of Business on entrepreneurship and leadership.KEEP READING
Chair of Department of Emergency Medicine, Tel Aviv Medical Center (145,000 adult visits/year, 220.000 total). He is Chair of the Tel Aviv University Division of Emergency Medicine and its founder. Involved in creating the specialty of Emergency Medicine in Israel in 1999 as President of the Israeli Association for Emergency Medicine. Heavily engaged in disaster preparedness and emergency medicine development in Israel. Pinchas (“Pinny”) Halpern, M.D., is Associate Clinical Professor in Anesthesia, Critical Care and Emergency Medicine, Sackler Faculty of Medicine, Tel Aviv University, Israel and Chair – Department of Emergency Medicine, Tel Aviv Medical Center. He is Visiting Professor at the Universities of Eastern Piedmont, Italy and the Free University of Brussels, Belgium and Staff Member of the European Master of Disaster Medicine. 1992- current: Chief diving medical officer for the Israeli Bureau of sports diving. Past President of the Israeli Association for Emergency Medicine, Chair of the Medical Advisory Committee of Magen David Adom National EMS and member of its Board of Directors. Member of multiple national committees on emergency and disaster preparedness and leads the effort of critical care in disasters. Member of the Board of Directors or Medical Advisory Board of anumber of biotechnology companies and 20 years experience in medical device development and implementation. Prof. Halpern led training missions in Emergency and Disaster Medicine to Ethiopia, Uzbekistan, Azerbaijan, Turkey, Jordan, Poland, and USA among other places and participated in disaster relief efforts in the Turkey earthquake.
Mr. Efi Cohen Arazi, CEO and Co-Founder of Rainbow Medical, Israel’s leading medical device innovation house focused on inventing and developing game changing solutions for sizeable unmet market needs in the area of hypertension, ophthalmology, cardiology and diabetes. Rainbow Medical’s shareholders include Medtronic, Abbott and Sony corporations. Mr. Cohen-Arazi has over 25 years of experience in the medtech and biotech industries where he held executive management responsibility in both operations and business management. Prior to establishing Rainbow Medical, Mr. Cohen-Arazi served as Co-Founder & CEO of IntecPharma, Israel, a company specializing in drug development and delivery and as Chairman of CollPlant Ltd., a both public companies traded in Tel-Aviv stock exchange. Previously, Mr. Cohen-Arazi was GM & V.P., Site Head at California based Amgen Corporation, where he established and led several global strategic initiatives and partnerships to develop and manufacture blockbuster biopharmaceuticals. Prior to Amgen, Mr. Cohen-Arazi was Senior VP at Immunex Corporation in Washington and before that VP and General Manager at the Merck-Serono Group in Switzerland and Israel. Mr. Cohen-Arazi holds advanced degrees in Agriculture and Microbiology from the Hebrew University of JerusalemKEEP READING
Lior serves as the CEO of Incentive Incubator since 2005 and as General Partner at Peregrine Ventures. Incentive has managed to reach 7 exits (Valtech, Neovasc, Bballoon, NLT spine, Eurekify, Marketyze, Rocketick) and has received 7 excellence awards by the state of Israel for its performance. Lior has extensive experience in early stage investments due diligence, strategic planning, project management and business development. Working closely with entrepreneurs to establish successful companies. Prior to joining Incentive Lior served as the Deputy Program Director of the Incubators Program. Lior holds an MBA from Tel Aviv University and a BA in Economics and Business Management from the University of Haifa. Lior serves on the Boards of Memic, Eximo, Restore, Cordio, Magneto, Outsense, Sinusafe and Artack.KEEP READING
Tomer Epstein is the Medical Device & Digital Health Sector Manager at the Israel Export and International Cooperation Institute. He studied Medical Engineering at Afeka Tel Aviv Academic College where he focused on mechanics of physiological systems and being engaged in innovative medical device development for improving cognitive activity among disabled and brain damaged patients; then proceeded to the distinguished MoTIE Program at Tel Aviv University (MBA in Management of Technology, Innovation & Entrepreneurship).
For more than five years working at the Israel Export Institute he worked closely with more than 800 Israeli Life Science companies and startups, Tomer is particularly deep in Medical Device & Digital Health understanding their commercial needs abroad, identifying target markets and business opportunities, thus generating export oriented activities – all this through continuous communication with multinational and local companies and tight cooperation with the Foreign Diplomats and Israeli Commercial Attachés all over the world. Tomer runs the business activity of the Israeli National Pavilion pavilions on stage of MEDICA (Germany), HIMSS (US), CMEF (China), Africa Health (South Africa), MEDinISRAEL; he has a strong background in both trade and business development perspective and as a medical engineer he’s of course deeply into crazy range of tech developments and their advantages.
Tal is the Founder and CEO of Foriland Investments, a private company, focused in venture capital & private equity investments. Tal serves as a member of the board of directors of several private companies, mainly technology and life science oriented. Tal also serves as the chairman of the board of Xenia Venture Capital, a hi-tech investment company publicly traded in the Tel Aviv Stock Exchange and a co-owner of the Van Leer Xenia incubator.
Prior to his current positions, Tal worked in several international professional service firms (in Israel and abroad). Tal holds a BA in Economics and Accountancy and MBA, both from Tel Aviv University.KEEP READING
About the Role
Israel has built a world leading healthcare system, yet it is not a world leader in exporting health care solutions. The aim of Healthcare-israel is to turn Israel’s proven accomplishments in the healthcare arena into large scale export projects for the benefit and well-being of all nations as well as a source for economic growth for Israel’s economy and its healthcare system. As Managing Director of Healthcare-Israel Hagai is in charge of facilitating government to government agreements for the advancement of the healthcare system in Israel as well as developing Israeli organizations’ capabilities in international cooperation and finding partners around the world for cooperation projects in the field of healthcare.
Fields of Responsibility
Since 2006, Hagai has served in various positions in the Planning, Budgeting and Pricing Branch of the Ministry of Health. Initially, he worked as a budgeting economist, and later headed the team in charge of budgeting at the Ministry’s headquarters. Starting in 2013, he has served as the Deputy Director of the division, in charge of all budgeting activities of the ministry of health and government owned hospitals in Israel (approx. 13 billion NIS and over 20,000 employees). As part of his job, Hagai was in charge of preparation of the state annual health budget; approval and supervision of annual work plans of all ministry departments and hospitals; heading three teams of budgeting and planning coordinators; managing all budget-related contacts of the ministry with the ministry of finance’s budgeting unit and the Knesset and involved in leading reforms and central structural changes in the healthcare system, along with entities from the healthcare system and the government.
Board Member, Life Science Directorate at IEI
Michal Ben David, BBSC Industrial Eng., MBA is heading Business Strategy and Operations for Israel and APAC Region (part of Teva Global Operations). Previously CFO of Teva’s sites at Jerusalem and holds years of experience in the field of Management Consulting.KEEP READING
Ariel is the Managing Director of Fresenius Medical Care group in Israel.
include managing FMC Israel and all its local affiliates, execution of short and long-term business strategies in support of the mission to expand services and products to Fresnius patients as a leading renal service provider in Israel.
Before joining Fresenius Ariel gained significant local and international experience as General Manager and BD Manager Emerging Markets at Philips Healthcare Israel as well as other roles in the multinational pharma industry namely Business Unit Manager at Schering-Plough. Ariel started his career as a Key Account and then Diagnostics Business Unit manager at Teva Pharmaceuticals .
Ariel holds a Master Degree from the Hebrew University in Jerusalem in Biochemistry as well as an MBA from the Heriot-Watt Universityץ Ariel graduated Insead General Managers program in France.
Ronen Gadot serves as the CEO of ElMindA, a highly innovative neuro-technology big data and artificial intelligence company, as of 2008. Recognizing the significant unmet need in the diagnostics and treatment of brain related disorders, Ronen was the first investor in ElMindA and joined its board in 2006. Entrepreneurial leader of creative solutions that are making a difference, Ronen was selected by the World Economic Forum to serve on the counsel for the future of neuro-technology. Following an Air Force Career, Ronen held several positions at Silicon Valley based Applied Materials. Later, Ronen joined Philips and co-founded Philips’ Global Corporate Venture arm, making Philips one of the most active corporate investors in Israel. Ronen led Philips in a visionary pathway into Personalized Telemedicine Healthcare through an investment, joint venture and IPO of SHL Telemedicine, and became the CEO of its European subsidiary. Ronen is a former member of the IAF Aerobatic Team, holds a BSc in Industrial Engineering and an MBA from INSEAD.KEEP READING
President & CEO, SAREL Logistics Solutions & Products for Advanced Medicine LTD (2007- )
Deputy Director, SAREL Logistics Solutions & Products for Advanced Medicine LTD (2006-2007)
Director & Board Member, Medical Logistics, Sheba Medical Center (2005)
Lieutenant colonel, Head of Logistics Department, Medical Corps, IDF (2000-2005);
Commander, Logistic Center for Medical Equipment & Medicines, IDF (1997-2000)
Mr. Avi Buskila is currently the president and the chief executive officer of SAREL, Israel’s largest supplier for goods and services to the healthcare industry. Previously, he has served in Sheba Medical Center as a director of the medical logistics. Nine years ago, Mr. Buskila retired from a long military carrer with the rank of lieutenant colonel. His last military position was as the head of the logistics department of the Medical Corps. Mr. Buskila was born in 1961. He is a graduate of the MBA program at Ben Gurion University. He is the director of the Medical Corps Association, a member of the National Council for Logistics in Health and a member of the Forum leaders and senior members of the Israeli economy.KEEP READING